Chordate Medical Holding Stock Short Ratio
| CMH Stock | 12.55 0.25 1.95% |
Chordate Medical Holding fundamentals help investors to digest information that contributes to Chordate Medical's financial success or failures. It also enables traders to predict the movement of Chordate Stock. The fundamental analysis module provides a way to measure Chordate Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chordate Medical stock.
Chordate |
Chordate Medical Holding Company Short Ratio Analysis
Chordate Medical's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Chordate Medical Holding has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Chordate Fundamentals
| Return On Equity | -1.68 | |||
| Return On Asset | -0.71 | |||
| Operating Margin | (54.40) % | |||
| Current Valuation | 102.78 M | |||
| Shares Outstanding | 157.71 M | |||
| Shares Owned By Insiders | 39.97 % | |||
| Price To Book | 5.80 X | |||
| Price To Sales | 3,320 X | |||
| Revenue | 618.01 K | |||
| Gross Profit | 1.93 M | |||
| EBITDA | (16.85 M) | |||
| Net Income | (19.76 M) | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (17.43 M) | |||
| Earnings Per Share | (0.18) X | |||
| Beta | 1.27 | |||
| Market Capitalization | 80.99 M | |||
| Total Asset | 31.22 M | |||
| Net Asset | 31.22 M |
About Chordate Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chordate Medical Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chordate Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chordate Medical Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.